Works by Song, Yongping
Results: 151
A nomogram predicting contralateral central neck lymph node metastasis for papillary thyroid carcinoma.
- Published in:
- Journal of Surgical Oncology, 2016, v. 114, n. 6, p. 703, doi. 10.1002/jso.24403
- By:
- Publication type:
- Article
Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases.
- Published in:
- Blood Cancer Journal, 2025, v. 14, n. 1, p. 1, doi. 10.1038/s41408-025-01218-8
- By:
- Publication type:
- Article
Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00771-w
- By:
- Publication type:
- Article
Intermittent Intraoperative Neural Monitoring Technology in Minimally Invasive Video-Assisted Thyroidectomy: A Preliminary Study.
- Published in:
- Journal of Investigative Surgery, 2016, v. 29, n. 2, p. 93, doi. 10.3109/08941939.2015.1073411
- By:
- Publication type:
- Article
Cotransplantation of Haploidentical Mesenchymal Stem Cells to Reduce the Risk of Graft Failure in a Patient with Refractory Severe Aplastic Anemia.
- Published in:
- Acta Haematologica, 2008, v. 119, n. 3, p. 162, doi. 10.1159/000134015
- By:
- Publication type:
- Article
Severe Epidermal Necrolysis after Bortezomib Treatment for Multiple Myeloma.
- Published in:
- Acta Haematologica, 2007, v. 118, n. 2, p. 65, doi. 10.1159/000102604
- By:
- Publication type:
- Article
Arsenic trioxide for refractory aplastic anemia.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with imatinib.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 11, p. 1099, doi. 10.1007/s00277-010-0991-4
- By:
- Publication type:
- Article
Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 3, p. 261, doi. 10.1007/s00277-008-0599-0
- By:
- Publication type:
- Article
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients.
- Published in:
- Journal of Cancer Research & Therapeutics, 2024, v. 20, n. 7, p. 2133, doi. 10.4103/jcrt.jcrt_269_24
- By:
- Publication type:
- Article
Comparison of human post-embryonic, multipotent stem cells derived from various tissues.
- Published in:
- Biotechnology Letters, 2009, v. 31, n. 7, p. 929, doi. 10.1007/s10529-009-9968-6
- By:
- Publication type:
- Article
L-asparaginase-based regimen as a first-line treatment for newly diagnosed nasal type extranodal natural killer cell/T-cell lymphoma.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 11, n. 6, p. 2437, doi. 10.3892/etm.2016.3249
- By:
- Publication type:
- Article
Application of HACCP in Producting Process of Tartary Buckwheat.
- Published in:
- Agricultural Biotechnology (2164-4993), 2018, v. 7, n. 2, p. 151
- By:
- Publication type:
- Article
Comparing the application of mNGS after combined pneumonia in hematologic patients receiving hematopoietic stem cell transplantation and chemotherapy: A retrospective analysis.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.969126
- By:
- Publication type:
- Article
Venetoclax and low-dose cytarabine induced complete remission in a patient with high-risk acute myeloid leukemia: a case report.
- Published in:
- Frontiers of Medicine, 2018, v. 12, n. 5, p. 593, doi. 10.1007/s11684-018-0635-y
- By:
- Publication type:
- Article
Mechanisms of resistance to third-generation EGFR tyrosine kinase inhibitors.
- Published in:
- Frontiers of Medicine, 2016, v. 10, n. 4, p. 383, doi. 10.1007/s11684-016-0488-1
- By:
- Publication type:
- Article
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the "don't eat me" signal and activating the "eat me" signal.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01385-2
- By:
- Publication type:
- Article
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01334-z
- By:
- Publication type:
- Article
Targeting macrophages in hematological malignancies: recent advances and future directions.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01328-x
- By:
- Publication type:
- Article
Targeting CD47 for cancer immunotherapy.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01197-w
- By:
- Publication type:
- Article
An Extended Virtual Aperture Imaging Model for Through-the-wall Sensing and Its Environmental Parameters Estimation.
- Published in:
- Radioengineering, 2014, v. 23, n. 3, p. 842
- By:
- Publication type:
- Article
The polymorphisms of tumor necrosis factor-induced protein 3 gene may contribute to the susceptibility of chronic primary immune thrombocytopenia in Chinese population.
- Published in:
- Platelets, 2016, v. 27, n. 1, p. 26, doi. 10.3109/09537104.2015.1022142
- By:
- Publication type:
- Article
Unbiased Single‐Cell Sequencing of Hematopoietic and Immune Cells from Aplastic Anemia Reveals the Contributors of Hematopoiesis Failure and Dysfunctional Immune Regulation.
- Published in:
- Advanced Science, 2024, v. 11, n. 10, p. 1, doi. 10.1002/advs.202304539
- By:
- Publication type:
- Article
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 2, p. 129, doi. 10.20892/j.issn.2095-3941.2022.0585
- By:
- Publication type:
- Article
Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 4, p. 1066, doi. 10.20892/j.issn.2095-3941.2021.0040
- By:
- Publication type:
- Article
Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph+ B cell acute lymphoblastic leukemia.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.965932
- By:
- Publication type:
- Article
Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.985280
- By:
- Publication type:
- Article
Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.962552
- By:
- Publication type:
- Article
High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.779248
- By:
- Publication type:
- Article
Aberrant histone modification in CD19<sup>+</sup> B cells of patients with chronic lymphocytic leukemia.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 1173, doi. 10.2147/OTT.S121301
- By:
- Publication type:
- Article
The Synchronous Presence of Multiple Myelomas and Other Primary Malignant Tumors: Case Series with Literature Review.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 2829, doi. 10.2147/CMAR.S238288
- By:
- Publication type:
- Article
Effectiveness and Feasibility of Complementary Lung-RADS Version 1.1 in Risk Stratification for pGGN in LDCT Lung Cancer Screening in a Chinese Population.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 189, doi. 10.2147/CMAR.S232269
- By:
- Publication type:
- Article
Safety and efficacy of amulirafusp alfa (IMM0306), a fusion protein of CD20 monoclonal antibody with the CD47 binding domain of SIRPα, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a phase 1/2 study.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01646-2
- By:
- Publication type:
- Article
Outcome after short exposure to tyrosine kinase inhibitors in pregnant female patients with chronic myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01603-z
- By:
- Publication type:
- Article
Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01489-3
- By:
- Publication type:
- Article
CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01488-4
- By:
- Publication type:
- Article
Pluripotent stem cells exhibiting similar characteristics can be isolated from human fetal bone marrow, heart, liver, muscle, lung, derma, kidney, and fat.
- Published in:
- Frontiers of Medicine in China, 2007, v. 1, n. 2, p. 185, doi. 10.1007/s11684-007-0035-1
- By:
- Publication type:
- Article
Improved outcome of adults with aplastic anaemia treated with arsenic trioxide plus ciclosporin.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 2, p. 266, doi. 10.1111/bjh.12110
- By:
- Publication type:
- Article
Correction to: The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0993-9
- By:
- Publication type:
- Article
Research progress on exosomes derived from mesenchymal stem cells in hematological malignancies.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 162, doi. 10.1002/hon.2793
- By:
- Publication type:
- Article
Robust beamforming for dual‐function radar‐communication with imperfect channel state information.
- Published in:
- Electronics Letters (Wiley-Blackwell), 2023, v. 59, n. 17, p. 1, doi. 10.1049/ell2.12941
- By:
- Publication type:
- Article
Detection of multi-people micro-motions based on range–velocity–time points.
- Published in:
- Electronics Letters (Wiley-Blackwell), 2019, v. 55, n. 23, p. 1247, doi. 10.1049/el.2019.2419
- By:
- Publication type:
- Article
Detection of multi‐people micro‐motions based on range–velocity–time points.
- Published in:
- Electronics Letters (Wiley-Blackwell), 2019, v. 55, n. 23, p. 1247, doi. 10.1049/el.2019.2419
- By:
- Publication type:
- Article
Angiotensin-(1-7)-mediated Mas1 receptor/NF-κB-p65 signaling is involved in a cigarette smoke-induced chronic obstructive pulmonary disease mouse model.
- Published in:
- Environmental Toxicology, 2018, v. 33, n. 1, p. 5, doi. 10.1002/tox.22454
- By:
- Publication type:
- Article
Rice microtubule-associated protein OsMAP65-3.1, but not OsMAP65-3.2, plays a critical role in phragmoplast microtubule organization in cytokinesis.
- Published in:
- Frontiers in Plant Science, 2022, v. 13, p. 1, doi. 10.3389/fpls.2022.1030247
- By:
- Publication type:
- Article
Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1193237
- By:
- Publication type:
- Article